Alias
科研级 Ranibizumab ( 雷珠单抗 ), Anti-VEGFA Recombinant Antibody, Research Grade Ranibizumab
Molecular Name
Ranibizumab
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Protein Chemical Formula
C2158H3282N562O681S12
Target
VEGFA[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion.
Storage
该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。